Leveraging Cutting Edge Biotechnology Research in Japan For Stronger IP Portfolios and Research Prioritization

By Chie Mueller-Hillebrand Ph.D., David Adamovich Ph.D., and Drew Lowery, Ph.D. December 10, 2020 Japan is not the first country that comes to mind when Senior Managers and IP Attorneys within the Massachusetts Biotech sector discuss leading edge biotech research and its implications for research directions and IP. However, as the Nobel Prize awards [...]